| pubmed-article:8158520 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8158520 | lifeskim:mentions | umls-concept:C0013819 | lld:lifeskim |
| pubmed-article:8158520 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
| pubmed-article:8158520 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:8158520 | lifeskim:mentions | umls-concept:C0007776 | lld:lifeskim |
| pubmed-article:8158520 | lifeskim:mentions | umls-concept:C0022655 | lld:lifeskim |
| pubmed-article:8158520 | lifeskim:mentions | umls-concept:C0001613 | lld:lifeskim |
| pubmed-article:8158520 | lifeskim:mentions | umls-concept:C0025219 | lld:lifeskim |
| pubmed-article:8158520 | lifeskim:mentions | umls-concept:C0699864 | lld:lifeskim |
| pubmed-article:8158520 | lifeskim:mentions | umls-concept:C0039476 | lld:lifeskim |
| pubmed-article:8158520 | lifeskim:mentions | umls-concept:C1442792 | lld:lifeskim |
| pubmed-article:8158520 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:8158520 | lifeskim:mentions | umls-concept:C2917356 | lld:lifeskim |
| pubmed-article:8158520 | lifeskim:mentions | umls-concept:C2827424 | lld:lifeskim |
| pubmed-article:8158520 | lifeskim:mentions | umls-concept:C0249681 | lld:lifeskim |
| pubmed-article:8158520 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:8158520 | pubmed:dateCreated | 1994-5-19 | lld:pubmed |
| pubmed-article:8158520 | pubmed:abstractText | The effects of melatonin (3 mg/kg i.p.) and the melatonin receptor agonist S-20098 (3 mg/kg i.p.) on the vigilance states, electroencephalogram power spectra (0.25-25.0 Hz), and cortical temperature were determined in eight rats in the first 6-hr interval of the 12-hr light period. Compared to the vehicle injection both compounds reduced the power density in non-rapid eye movement sleep in the low frequency range (1-8 Hz) but did not affect the vigilance states and brain temperature. The present findings do not indicate that the stimulation of the melatonin receptor exerts a hypnotic effect at doses that had been shown to affect the circadian rest-activity rhythm. | lld:pubmed |
| pubmed-article:8158520 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8158520 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8158520 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8158520 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8158520 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8158520 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8158520 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8158520 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8158520 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8158520 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:8158520 | pubmed:issn | 0742-3098 | lld:pubmed |
| pubmed-article:8158520 | pubmed:author | pubmed-author:BorbélyA AAA | lld:pubmed |
| pubmed-article:8158520 | pubmed:author | pubmed-author:ToblerII | lld:pubmed |
| pubmed-article:8158520 | pubmed:author | pubmed-author:JaggiKK | lld:pubmed |
| pubmed-article:8158520 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8158520 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:8158520 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8158520 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8158520 | pubmed:pagination | 26-32 | lld:pubmed |
| pubmed-article:8158520 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8158520 | pubmed:meshHeading | pubmed-meshheading:8158520-... | lld:pubmed |
| pubmed-article:8158520 | pubmed:meshHeading | pubmed-meshheading:8158520-... | lld:pubmed |
| pubmed-article:8158520 | pubmed:meshHeading | pubmed-meshheading:8158520-... | lld:pubmed |
| pubmed-article:8158520 | pubmed:meshHeading | pubmed-meshheading:8158520-... | lld:pubmed |
| pubmed-article:8158520 | pubmed:meshHeading | pubmed-meshheading:8158520-... | lld:pubmed |
| pubmed-article:8158520 | pubmed:meshHeading | pubmed-meshheading:8158520-... | lld:pubmed |
| pubmed-article:8158520 | pubmed:meshHeading | pubmed-meshheading:8158520-... | lld:pubmed |
| pubmed-article:8158520 | pubmed:meshHeading | pubmed-meshheading:8158520-... | lld:pubmed |
| pubmed-article:8158520 | pubmed:meshHeading | pubmed-meshheading:8158520-... | lld:pubmed |
| pubmed-article:8158520 | pubmed:meshHeading | pubmed-meshheading:8158520-... | lld:pubmed |
| pubmed-article:8158520 | pubmed:meshHeading | pubmed-meshheading:8158520-... | lld:pubmed |
| pubmed-article:8158520 | pubmed:meshHeading | pubmed-meshheading:8158520-... | lld:pubmed |
| pubmed-article:8158520 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8158520 | pubmed:articleTitle | Effects of melatonin and the melatonin receptor agonist S-20098 on the vigilance states, EEG spectra, and cortical temperature in the rat. | lld:pubmed |
| pubmed-article:8158520 | pubmed:affiliation | Institute of Pharmacology, University of Zürich, Switzerland. | lld:pubmed |
| pubmed-article:8158520 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8158520 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8158520 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8158520 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8158520 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8158520 | lld:pubmed |
